By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Epistem Holdings said that it plans to raise £2.8 million ($4.4 million) through the placement of 793,398 new ordinary shares at 350 pence each.

The offering price is a slight discount to the trading price of around 362.5 pence before the placement was announced Friday. The Manchester, UK-based firm said that it has conditionally placed the shares with unnamed existing and new institutional investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.